Androgens and hair loss

Area of Science:

• Dermatology
• Genetics
• Pharmacology

Background:

• Androgenetic alopecia (AGA), or male pattern hair loss, is a prevalent condition with significant psychosocial effects.
• Recent advancements have improved understanding of AGA's pathogenesis and treatment.

Purpose of the Study:

• To review recent developments in the pathogenesis and treatment of androgenetic alopecia.
• To discuss the implications of new findings for future AGA management.

Main Methods:

• Review of recent scientific literature on AGA.
• Analysis of genome-wide association studies and clinical trial data.
• Evaluation of in-vitro studies on novel drug formulations.

Main Results:

• Genome-wide analysis identified associations between AGA and chromosomes 20p11 and 3q26, as well as the androgen-receptor gene.
• Dutasteride demonstrated greater efficacy than finasteride for AGA treatment, though not yet standard.
• A novel topical liposomal finasteride formulation exhibited over five-fold increased skin drug deposition compared to a plain solution.

Conclusions:

• Emerging developments in AGA research offer potential for improved future management strategies.
• Genetic discoveries and advanced drug delivery systems represent promising avenues for treating male pattern hair loss.